Over expression of other tyrosine kinase receptors such as HER-2, c-MET has also been widely reported in the case of HNSCC enabling resistance towards receptor targeting monoclonal antibody therapies against HNSCC [60]
One of the few published studies of BP-157 involving humans was a very small, low-quality study with 16 participants with knee pain
Twelve remaining articles were assessed for eligibility
If you experience unexpected symptoms after starting BPC-157whether physical discomfort, unusual fatigue, changes in mood, or any concerning signsdiscontinue use and consult a healthcare provider for evaluation
GHK-Cu vs NAD+: A Clinical Comparison of Two Longevity Peptide Therapies GHK-Cu and NAD+ target aging from opposite directions
Side Effect 2: Digestive System Effects Gastrointestinal reactions can occur, including mild diarrhea and occasional constipation [9]